Antonella Cordoba/LinkedIn
Aug 9, 2026, 15:16
Antonella Cordoba: Emicizumab and the Evolving Landscape of Hemophilia A
Antonella Cordoba, Médica Hematologa at Hospital General de Agudos José Maria Penna, shared a post on LinkedIn:
”The meeting organized by Roche on Hemlibra (emicizumab) and the new advances in the treatment of hemophilia A was very enriching.
A space for updating and exchange on how innovation continues to transform the approach to hemorrhagic diseases.
Thank you Guillermo Rabossi for the invitation and for generating these learning spaces.”
-
Sep 24, 2026, 16:02Leonardo Roever: Understanding Peripheral Artery Disease in the Modern Era
-
Sep 24, 2026, 15:49Sthanu Subramanian: When HbA1c Does Not Reflect True Glycemia
-
Sep 24, 2026, 15:09Caroline Voltz-Girolt: Accelerating the Development of Innovative Therapies for Rare Blood Disorders
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care